Emerging mechanistic insights of selective autophagy in hepatic diseases

ALIM AL-BARI, Abdul, ITO, Yuko, THOMES, Paul G., MENON, Manoj B., GARCÍA-MACIA, Marina, FADEL, Raouf, STADLIN, Alfreda, PEAKE, Nicholas, FARIS, MoezAlIslam Ezzat, EID, Nabil and KLIONSKY, Daniel J. (2023). Emerging mechanistic insights of selective autophagy in hepatic diseases. Frontiers in Pharmacology, 14.

fphar-14-1149809.pdf - Published Version
Creative Commons Attribution.

Download (4MB) | Preview
DataSheet1.pdf - Supplemental Material
Creative Commons Attribution.

Download (792kB) | Preview
Official URL: https://www.frontiersin.org/articles/10.3389/fphar...
Open Access URL: https://www.frontiersin.org/articles/10.3389/fphar... (Published version)
Link to published version:: https://doi.org/10.3389/fphar.2023.1149809


Macroautophagy (hereafter referred to as autophagy), a highly conserved metabolic process, regulates cellular homeostasis by degrading dysfunctional cytosolic constituents and invading pathogens via the lysosomal system. In addition, autophagy selectively recycles specific organelles such as damaged mitochondria (via mitophagy), and lipid droplets (LDs; via lipophagy) or eliminates specialized intracellular pathogenic microorganisms such as hepatitis B virus (HBV) and coronaviruses (via virophagy). Selective autophagy, particularly mitophagy, plays a key role in the preservation of healthy liver physiology, and its dysfunction is connected to the pathogenesis of a wide variety of liver diseases. For example, lipophagy has emerged as a defensive mechanism against chronic liver diseases. There is a prominent role for mitophagy and lipophagy in hepatic pathologies including non-alcoholic fatty liver disease (NAFLD), hepatocellular carcinoma (HCC), and drug-induced liver injury. Moreover, these selective autophagy pathways including virophagy are being investigated in the context of viral hepatitis and, more recently, the coronavirus disease 2019 (COVID-19)-associated hepatic pathologies. The interplay between diverse types of selective autophagy and its impact on liver diseases is briefly addressed. Thus, modulating selective autophagy (e.g., mitophagy) would seem to be effective in improving liver diseases. Considering the prominence of selective autophagy in liver physiology, this review summarizes the current understanding of the molecular mechanisms and functions of selective autophagy (mainly mitophagy and lipophagy) in liver physiology and pathophysiology. This may help in finding therapeutic interventions targeting hepatic diseases via manipulation of selective autophagy.

Item Type: Article
Additional Information: ** From Frontiers via Jisc Publications Router ** Licence for this article: http://creativecommons.org/licenses/by/4.0/ ** Peer reviewed: TRUE **Journal IDs: eissn 1663-9812 **Article IDs: publisher-id: 1149809 **History: published_online 16-03-2023; accepted 23-02-2023; submitted 23-01-2023; collection 2023
Uncontrolled Keywords: Pharmacology, autophagy, lipophagy, liver disease, mitophagy, TFEB, virophagy
Identification Number: https://doi.org/10.3389/fphar.2023.1149809
SWORD Depositor: Colin Knott
Depositing User: Colin Knott
Date Deposited: 03 Apr 2023 10:13
Last Modified: 11 Oct 2023 16:15
URI: https://shura.shu.ac.uk/id/eprint/31708

Actions (login required)

View Item View Item


Downloads per month over past year

View more statistics